122 related articles for article (PubMed ID: 37477521)
1. Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells.
Filon M; Yang B; Purohit TA; Schehr J; Singh A; Bigarella M; Lewis P; Denu J; Lang J; Jarrard DF
Oncotarget; 2023 Jul; 14():738-746. PubMed ID: 37477521
[TBL] [Abstract][Full Text] [Related]
2. Identifying Dysregulated Epigenetic Enzyme Activity in Castrate-Resistant Prostate Cancer Development.
Lee JH; Yang B; Lindahl AJ; Damaschke N; Boersma MD; Huang W; Corey E; Jarrard DF; Denu JM
ACS Chem Biol; 2017 Nov; 12(11):2804-2814. PubMed ID: 28949514
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes.
Damodaran S; Damaschke N; Gawdzik J; Yang B; Shi C; Allen GO; Huang W; Denu J; Jarrard D
BMC Cancer; 2017 Dec; 17(1):874. PubMed ID: 29262808
[TBL] [Abstract][Full Text] [Related]
4. Differences in specificity and selectivity between CBP and p300 acetylation of histone H3 and H3/H4.
Henry RA; Kuo YM; Andrews AJ
Biochemistry; 2013 Aug; 52(34):5746-59. PubMed ID: 23862699
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation.
Jin Q; Yu LR; Wang L; Zhang Z; Kasper LH; Lee JE; Wang C; Brindle PK; Dent SY; Ge K
EMBO J; 2011 Jan; 30(2):249-62. PubMed ID: 21131905
[TBL] [Abstract][Full Text] [Related]
6. Modulation of p300/CBP Acetylation of Nucleosomes by Bromodomain Ligand I-CBP112.
Zucconi BE; Luef B; Xu W; Henry RA; Nodelman IM; Bowman GD; Andrews AJ; Cole PA
Biochemistry; 2016 Jul; 55(27):3727-34. PubMed ID: 27332697
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
Lasko LM; Jakob CG; Edalji RP; Qiu W; Montgomery D; Digiammarino EL; Hansen TM; Risi RM; Frey R; Manaves V; Shaw B; Algire M; Hessler P; Lam LT; Uziel T; Faivre E; Ferguson D; Buchanan FG; Martin RL; Torrent M; Chiang GG; Karukurichi K; Langston JW; Weinert BT; Choudhary C; de Vries P; Van Drie JH; McElligott D; Kesicki E; Marmorstein R; Sun C; Cole PA; Rosenberg SH; Michaelides MR; Lai A; Bromberg KD
Nature; 2017 Oct; 550(7674):128-132. PubMed ID: 28953875
[TBL] [Abstract][Full Text] [Related]
8. p300-Mediated Acetylation of Histone Demethylase JMJD1A Prevents Its Degradation by Ubiquitin Ligase STUB1 and Enhances Its Activity in Prostate Cancer.
Xu S; Fan L; Jeon HY; Zhang F; Cui X; Mickle MB; Peng G; Hussain A; Fazli L; Gleave ME; Dong X; Qi J
Cancer Res; 2020 Aug; 80(15):3074-3087. PubMed ID: 32522824
[TBL] [Abstract][Full Text] [Related]
9. Acetylation of Sirt2 by p300 attenuates its deacetylase activity.
Han Y; Jin YH; Kim YJ; Kang BY; Choi HJ; Kim DW; Yeo CY; Lee KY
Biochem Biophys Res Commun; 2008 Oct; 375(4):576-80. PubMed ID: 18722353
[TBL] [Abstract][Full Text] [Related]
10. The SIRT2 deacetylase regulates autoacetylation of p300.
Black JC; Mosley A; Kitada T; Washburn M; Carey M
Mol Cell; 2008 Nov; 32(3):449-55. PubMed ID: 18995842
[TBL] [Abstract][Full Text] [Related]
11. The HTLV-1-encoded protein HBZ directly inhibits the acetyl transferase activity of p300/CBP.
Wurm T; Wright DG; Polakowski N; Mesnard JM; Lemasson I
Nucleic Acids Res; 2012 Jul; 40(13):5910-25. PubMed ID: 22434882
[TBL] [Abstract][Full Text] [Related]
12. Targeting the p300/CBP Axis in Lethal Prostate Cancer.
Welti J; Sharp A; Brooks N; Yuan W; McNair C; Chand SN; Pal A; Figueiredo I; Riisnaes R; Gurel B; Rekowski J; Bogdan D; West W; Young B; Raja M; Prosser A; Lane J; Thomson S; Worthington J; Onions S; Shannon J; Paoletta S; Brown R; Smyth D; Harbottle GW; Gil VS; Miranda S; Crespo M; Ferreira A; Pereira R; Tunariu N; Carreira S; Neeb AJ; Ning J; Swain A; Taddei D; ; Schiewer MJ; Knudsen KE; Pegg N; de Bono JS
Cancer Discov; 2021 May; 11(5):1118-1137. PubMed ID: 33431496
[TBL] [Abstract][Full Text] [Related]
13. CBP/p300-mediated acetylation of histone H3 on lysine 56.
Das C; Lucia MS; Hansen KC; Tyler JK
Nature; 2009 May; 459(7243):113-7. PubMed ID: 19270680
[TBL] [Abstract][Full Text] [Related]
14. Promoter-specific changes in initiation, elongation, and homeostasis of histone H3 acetylation during CBP/p300 inhibition.
Hsu E; Zemke NR; Berk AJ
Elife; 2021 Mar; 10():. PubMed ID: 33704060
[TBL] [Abstract][Full Text] [Related]
15. Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition.
Hogg SJ; Motorna O; Cluse LA; Johanson TM; Coughlan HD; Raviram R; Myers RM; Costacurta M; Todorovski I; Pijpers L; Bjelosevic S; Williams T; Huskins SN; Kearney CJ; Devlin JR; Fan Z; Jabbari JS; Martin BP; Fareh M; Kelly MJ; Dupéré-Richer D; Sandow JJ; Feran B; Knight D; Khong T; Spencer A; Harrison SJ; Gregory G; Wickramasinghe VO; Webb AI; Taberlay PC; Bromberg KD; Lai A; Papenfuss AT; Smyth GK; Allan RS; Licht JD; Landau DA; Abdel-Wahab O; Shortt J; Vervoort SJ; Johnstone RW
Mol Cell; 2021 May; 81(10):2183-2200.e13. PubMed ID: 34019788
[TBL] [Abstract][Full Text] [Related]
16. Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome.
Weinert BT; Narita T; Satpathy S; Srinivasan B; Hansen BK; Schölz C; Hamilton WB; Zucconi BE; Wang WW; Liu WR; Brickman JM; Kesicki EA; Lai A; Bromberg KD; Cole PA; Choudhary C
Cell; 2018 Jun; 174(1):231-244.e12. PubMed ID: 29804834
[TBL] [Abstract][Full Text] [Related]
17. Targeting CDCP1 gene transcription coactivated by BRD4 and CBP/p300 in castration-resistant prostate cancer.
Ji D; Shang G; Wei E; Jia Y; Wang C; Zhang Q; Zeng L
Oncogene; 2022 Jun; 41(23):3251-3262. PubMed ID: 35513563
[TBL] [Abstract][Full Text] [Related]
18. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H
Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703
[TBL] [Abstract][Full Text] [Related]
19. 5-Fluorouracil targets histone acetyltransferases p300/CBP in the treatment of colorectal cancer.
Du C; Huang D; Peng Y; Yao Y; Zhao Y; Yang Y; Wang H; Cao L; Zhu WG; Gu J
Cancer Lett; 2017 Aug; 400():183-193. PubMed ID: 28465257
[TBL] [Abstract][Full Text] [Related]
20. Histone Acetyltransferases p300 and CBP Coordinate Distinct Chromatin Remodeling Programs in Vascular Smooth Muscle Plasticity.
Chakraborty R; Ostriker AC; Xie Y; Dave JM; Gamez-Mendez A; Chatterjee P; Abu Y; Valentine J; Lezon-Geyda K; Greif DM; Schulz VP; Gallagher PG; Sessa WC; Hwa J; Martin KA
Circulation; 2022 Jun; 145(23):1720-1737. PubMed ID: 35502657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
